VIVAN Therapeutics

About:

VIVAN Therapeutics is a company pioneering personalized cancer therapeutics using a new assay technology.

Website: https://www.vivantx.com

Twitter/X: mypersonalthera

Top Investors: European Innovation Council, SFC Capital, Reflect Ventures, VOYAGERS Health-Tech Fund

Description:

VIVAN Therapeutics, a company pioneering personalized cancer therapeutics using a new assay technology. MPT licensed technology from the Center for Personalized Cancer Therapeutics at Mt Sinai New York and is launching the world’s most comprehensive, personal genomics-based, block-chain enabled drug screening service. All recommended treatment combinations will include a cancer drug and a non cancer drug, making treatments less toxic and more affordable. Intelligently designed personalized treatment. Revolutionary cancer care.

Total Funding Amount:

3.4M GBP

Headquarters Location:

London, England, United Kingdom

Founded Date:

2018-01-01

Contact Email:

laura(AT)vivantx.com

Founders:

Laura Towart

Number of Employees:

11-50

Last Funding Date:

2022-12-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai